Insulin dosing decision support for diabetes patients

Software/app helping Type 1 diabetes patients calculate correct insulin doses based on blood glucose, meals, and activity.

YC GraveyardJun 1, 2016ToolMedicine & HealthSource

FL score

out of 100

Verdict

VALIDATE

high confidence

Competition

competitors found, emerging market, funded players

Trend

1 community mentions

A high-stakes insulin dosing decision support tool for Type 1 diabetes patients facing fierce competition and complex trust/regulatory hurdles.

The pain

Type 1 diabetes patients constantly face the critical and dangerous task of calculating precise insulin doses based on blood glucose, food intake, and activity. Errors can lead to severe health consequences. Existing apps are often glitchy, slow, lack custom medication tracking, or have complex manual food logging, causing daily frustration.

The gap

Despite a crowded market with funded competitors (mySugr, Diabetes:M, Glooko, Sugarmate, Tidepool Loop), specific user frustrations regarding reliability, customizability (e.g., custom meds, default insulin settings), and ease of use (e.g., food logging) exist. The solo builder angle proposes a non-FDA-regulated decision-support tool focused on popular CGMs (Dexcom, Freestyle), targeting these specific pain points.

Build angle

Develop a highly reliable, user-friendly insulin dosing calculator for Type 1 diabetes patients that integrates seamlessly with popular CGMs (Dexcom, Freestyle). Focus on addressing specific user frustrations like managing custom medications, consistent default insulin settings, and simplifying food logging, explicitly positioning it as a non-FDA-regulated educational/calculation tool, not medical advice. Build trust through transparent methodology and strong community engagement.

Strengths

Addresses an extremely real, severe, and daily pain point for a large, engaged user base.
Clear willingness to pay signals from existing app subscriptions and user frustrations.
Growing market for digital diabetes management, with a trend towards AI-driven solutions.
Specific user complaints about current tools provide concrete angles for improvement.

Risks

Highly crowded market with well-funded competitors and even FDA-cleared automated solutions.
Extreme build complexity and high stakes for accuracy/reliability given the health implications.
Navigating regulatory perception (even as 'non-medical advice') is a significant challenge, as evidenced by YC graveyard company DoseDr.
Building trust and distribution as a solo builder in a health-critical domain is difficult.
Creator fit for a solo builder without specialized medical/diabetes expertise is low.

Next steps

Conduct in-depth interviews with Type 1 diabetes patients who use existing apps to precisely quantify their most severe and frequent frustrations.
Investigate the technical feasibility and actual effort required for reliable CGM integration and a robust, accurate calculation engine, considering edge cases.
Explore potential partnerships with diabetes educators or patient advocacy groups to build credibility and refine the 'non-medical advice' positioning.

Fly Labs Method

Is the pain real, is there a gap, is it the right time, can one person build it.

Problem clarity: 27
Solution gap: 11
Willingness to pay: 20
Buildability: 4

A real, severe problem with clear willingness to pay, but the market is heavily crowded and building a reliable, health-critical tool as a solo builder, even with a narrow non-FDA angle, presents significant risks and complexity.

Value Equation

Dream outcome and how likely it feels, against the time and effort it costs.

The market for diabetes management is large with clear pain, but competition and regulatory challenges make differentiation and solo execution difficult.

One-Person Business

Curiosity pull, identity fit, and a path from free value to paid for a solo creator.

Clear problem and good audience reach, but significant challenges in creator fit, complexity, and carving out a defensible niche as a solo founder in a health-critical, competitive space.

Viral Frameworks

Hook strength, shareability, and how cheaply it can be tested.

Specific audience and clear value prop, but high risks related to trust, regulatory ambiguity, and direct competition with well-funded incumbents make validation and scaling challenging.

Builder Lens

Evidence the problem exists, timing, defensibility, and a model that fits on a napkin.

High demand and clear pain points exist, but the narrowest wedge is still complex, and competing against future-fit, integrated solutions is a challenge.

Why this verdict

The idea tackles a critical, high-frequency problem with clear demand and payment signals. However, the extremely crowded market, high build complexity, significant regulatory and trust hurdles, and low solo builder fit make this a high-risk endeavor. While there's a narrow angle in addressing specific user frustrations and leveraging clearer FDA guidance, successfully executing and gaining traction as a solo builder without significant domain expertise is exceptionally challenging. Deep validation of the specific 'whitespace' and the solo builder's capability is essential before committing to a full build, especially given the YC graveyard context.

Five lenses, one composite. How scoring works

The angle

This weekend

Conduct in-depth interviews with Type 1 diabetes patients who use existing apps to precisely quantify their most severe and frequent frustrations.
Investigate the technical feasibility and actual effort required for reliable CGM integration and a robust, accurate calculation engine, considering edge cases.
Explore potential partnerships with diabetes educators or patient advocacy groups to build credibility and refine the 'non-medical advice' positioning.

Who is already there, emerging market

mySugrFundedVisit
A diabetes management app that tracks blood sugar, meals, activity, and insulin doses with a gamified interface and offers an insulin bolus calculator.
Pricing: Basic features are free. A paid subscription (mySugr Pro) unlocks advanced features like insulin bolus advisor and reminders.
Diabetes:MVisit
A comprehensive mobile app for tracking and managing all types of diabetes, offering an insulin bolus calculator, food database, and detailed reports.
Pricing: Free basic app with in-app purchases and a subscription plan for additional features like no ads, Bluetooth integration, and multiple profiles.
GlookoFundedVisit
A mobile and desktop-friendly app that aggregates data from various diabetes devices (CGMs, pumps, BGMs) and allows digital sharing with healthcare providers.
Pricing: Not directly specified for patients; primarily a platform for clinicians and healthcare facilities. Offers different upload methods depending on the device.
Sugarmate by TandemFundedVisit
An app that visualizes CGM data, offers customizable alerts (including low glucose calls), and allows tracking of activity, nutrition, and insulin delivery.
Pricing: Not explicitly stated on the website, but generally functions as a companion app for Dexcom CGM users.
xDrip+Visit
An open-source Android application that displays data from blood glucose monitoring devices, highly customizable with various integrations.
Pricing: Free and open source.
Tidepool LoopFundedVisit
The first FDA-cleared interoperable automated insulin dosing app that automates basal insulin delivery based on predicted glucose levels.
Pricing: Not explicitly stated, but as an FDA-cleared interoperable app, it will likely be integrated with compatible insulin pumps and CGMs.
DosecastVisit
A medication management app that provides flexible scheduling options and comprehensive tracking features for remembering to take medication.
Pricing: Basic features are free. A paid version costs $2.99 per month or $27.99 per year for advanced features like data synchronization, progress reports, and refill reminders.

Funded players

What they charge

The pricing landscape for insulin dosing decision support apps for Type 1 diabetes varies. Many apps offer a freemium model with basic features available for free and advanced features locked behind a subscription (e.g., mySugr, Diabetes:M, Dosecast). Pricing for premium features can range from a few dollars per month to around $30 per month, with some including additional hardware like glucose meters and test strips. Some open-source alternatives like xDrip+ are entirely free. Enterprise pricing exists for platforms like Glooko, which are designed for healthcare providers and integrate with various devices.

What people say, 1 mentions

Built a peptide research platform solo, went viral (270 upvotes, 60k views in just days), then got mysteriously banned - here's the full story and I'd love your feedback
r/SaaS

r/r/SaaS

Insulin dosing decision support for diabetes patients

Preventive and restorative tooth care alternatives to root canal

Fertility tracking and ovulation prediction through accessible testing

Asynchronous telemedicine for chronic dermatology conditions